What Can CMR Contribute to the Characterization of Non-Ischemic Cardiomyopathies?
Edythe Tham1
1Stollery Children's Hospital, Canada

Synopsis

Keywords: Cardiovascular: Cardiac, Cardiovascular: Cardiac function, Cardiovascular: Myocardium

CMR has developed beyond anatomical imaging to provide functional assessment and myocardial tissue characterization providing a powerful diagnostic tool in cardiomyopathies. Fibrosis is the final common pathway of myocardial diseases from a variety of insults and is associated with declining ventricular function. Late gadolinium enhancement can detect focal myocardial fibrosis; while T2 mapping (edema), T1 mapping and extracellular volume (diffuse fibrosis), provide quantitative parameters that are used in the diagnosis, management and follow up of patients with non-ischemic cardiomyopathies. A shift towards these imaging parameters should provide a non-invasive serial marker to assess response to treatments and may predict outcome.

Slide #1
Slide #2
Slide #3
Slide #4
Slide #5
Slide #6
Slide #7
Slide #8
Slide #9
Slide #10
Slide #11
Slide #12
Slide #13
Slide #14
Slide #15
Slide #16
Slide #17
Slide #18
Slide #19
Slide #20
Slide #21
Slide #22
Slide #23
Slide #24
Slide #25
Slide #26
Slide #27
Slide #28
Slide #29
Slide #30
Proc. Intl. Soc. Mag. Reson. Med. 32 (2024)